US 11,890,015 B2
Compressible adjunct with crossing spacer fibers
Michael J. Vendely, Lebanon, OH (US); Frederick E. Shelton, IV, Hillsboro, OH (US); Jason L. Harris, Lebanon, OH (US); Charles J. Scheib, Loveland, OH (US); Howell T. Goldrein, Cambridge (GB); Robert S. Moir, Cambridge (GB); Sofia Maria Consonni, Birmingham (GB); Ismail Akram, Cambridge (GB); Ashley D. Easter, Cambridge (GB); and Helen S. Latham, Cambridge (GB)
Assigned to Cilag GmbH International, Zug (CH)
Filed by Cilag GmbH International, Zug (CH)
Filed on Sep. 9, 2021, as Appl. No. 17/470,391.
Application 17/470,391 is a continuation of application No. 17/061,764, filed on Oct. 2, 2020, granted, now 11,553,916.
Application 17/061,764 is a continuation of application No. 16/229,607, filed on Dec. 21, 2018, granted, now 10,932,779, issued on Mar. 2, 2021.
Application 16/229,607 is a continuation of application No. 14/871,071, filed on Sep. 30, 2015, granted, now 10,433,846, issued on Oct. 8, 2019.
Prior Publication US 2022/0061843 A1, Mar. 3, 2022
Int. Cl. A61B 17/072 (2006.01); A61B 17/10 (2006.01); A61B 17/064 (2006.01); B32B 5/02 (2006.01); B32B 5/10 (2006.01); B32B 5/12 (2006.01); B32B 5/18 (2006.01); B32B 5/24 (2006.01); B32B 5/26 (2006.01); B32B 3/02 (2006.01); B32B 3/08 (2006.01); B32B 3/20 (2006.01); B32B 3/26 (2006.01); B29C 48/16 (2019.01); A61B 17/00 (2006.01); A61B 17/32 (2006.01); A61B 17/08 (2006.01); A61L 17/10 (2006.01); A61L 17/12 (2006.01); B05D 1/00 (2006.01); B05D 1/30 (2006.01); D01D 5/00 (2006.01); D01D 5/18 (2006.01); D04H 1/56 (2006.01); B32B 7/05 (2019.01); A61B 17/068 (2006.01); B29L 31/00 (2006.01); B29C 44/34 (2006.01); B29C 48/05 (2019.01); B29C 48/00 (2019.01)
CPC A61B 17/105 (2013.01) [A61B 17/00491 (2013.01); A61B 17/068 (2013.01); A61B 17/0644 (2013.01); A61B 17/072 (2013.01); A61B 17/07207 (2013.01); A61B 17/07292 (2013.01); A61B 17/08 (2013.01); A61B 17/32 (2013.01); A61L 17/105 (2013.01); A61L 17/12 (2013.01); B05D 1/007 (2013.01); B05D 1/30 (2013.01); B29C 48/16 (2019.02); B32B 3/02 (2013.01); B32B 3/08 (2013.01); B32B 3/20 (2013.01); B32B 3/266 (2013.01); B32B 5/024 (2013.01); B32B 5/026 (2013.01); B32B 5/10 (2013.01); B32B 5/12 (2013.01); B32B 5/18 (2013.01); B32B 5/245 (2013.01); B32B 5/26 (2013.01); B32B 7/05 (2019.01); D01D 5/0023 (2013.01); D01D 5/18 (2013.01); D04H 1/565 (2013.01); A61B 2017/00004 (2013.01); A61B 2017/00477 (2013.01); A61B 2017/00526 (2013.01); A61B 2017/00831 (2013.01); A61B 2017/00862 (2013.01); A61B 2017/00893 (2013.01); A61B 2017/00955 (2013.01); A61B 2017/00964 (2013.01); A61B 2017/0725 (2013.01); A61B 2017/07214 (2013.01); A61B 2017/07221 (2013.01); A61B 2017/07228 (2013.01); A61B 2017/07235 (2013.01); A61B 2017/07242 (2013.01); A61B 2017/07257 (2013.01); A61B 2017/07271 (2013.01); A61B 2017/07278 (2013.01); A61B 2017/07285 (2013.01); A61L 2420/02 (2013.01); B29C 44/3453 (2013.01); B29C 44/358 (2013.01); B29C 48/0012 (2019.02); B29C 48/0022 (2019.02); B29C 48/05 (2019.02); B29L 2031/753 (2013.01); B29L 2031/7546 (2013.01); B32B 2250/03 (2013.01); B32B 2250/40 (2013.01); B32B 2307/50 (2013.01); B32B 2307/54 (2013.01); B32B 2307/72 (2013.01); B32B 2307/732 (2013.01); B32B 2307/736 (2013.01); B32B 2535/00 (2013.01); D10B 2331/041 (2013.01); D10B 2509/00 (2013.01)] 16 Claims
OG exemplary drawing
 
1. A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises:
a staple cartridge, comprising:
a plurality of staples; and
a cartridge deck; and
a compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises:
a first biocompatible layer comprising a first portion;
a second biocompatible layer comprising a second portion, wherein the first biocompatible layer is spaced apart from the second biocompatible layer; and
a plurality of discrete crossed spacer fibers extending between the first portion and the second portion, wherein the plurality of discrete crossed spacer fibers comprises:
a first spacer fiber; and
a second spacer fiber crossing the first spacer fiber in a space defined and maintained outside the first biocompatible layer and the second biocompatible layer by the plurality of discrete crossed spacer fibers, and wherein each of the first and second spacer fibers comprise:
a first end portion directly attached to the first biocompatible layer; and
a second end portion directly attached to the second biocompatible layer.